U K
B U S I N E S S
P A R K
home page

The information below comes from the UK Activity Report.
Click here for further details

Acambis Acambis is to raise £40m in a share placing to fund the expansion of its vaccine manufacturing and research business, which includes sites in Cambridge and the US. 24-Apr-2008 Acambis has sold Berna Products, the US-based distributor of oral typhoid vaccines with 15 staff, to Crucell for £9m. 03-Oct-2006 Acambis has acquired a US-based 58,000 sq ft vaccine manufacturing facility in Rockville, MD, from BioReliance Corporation for £4m. 11-May-2005 Acambis is to close its vaccine research centre in Cambridge with the loss of 40 jobs, in order to focus its biotechnology research activities in the US. 02-Feb-2004 Acambis has secured a £28m capital injection from Baxter Healthcare to fund the refurbishment of a US plant to produce the smallpox vaccine. 06-Dec-2001 Peptide Therapeutics is to receive a £28m investment from Baxter of the US in exchange for a 20% stake, and the company will be renamed Acambis. 21-Sep-2000 The information above comes from the UK Activity Report Copyright UK Business Park 1995-2008